These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 14559089)
1. Antimicrobial strategies for the prevention and treatment of cardiovascular infections. Furuya EY; Lowy FD Curr Opin Pharmacol; 2003 Oct; 3(5):464-9. PubMed ID: 14559089 [TBL] [Abstract][Full Text] [Related]
2. Infections of intracardiac devices. Karchmer AW; Longworth DL Infect Dis Clin North Am; 2002 Jun; 16(2):477-505, xii. PubMed ID: 12092483 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance. Lee SY; Kuti JL; Nicolau DP Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938 [TBL] [Abstract][Full Text] [Related]
8. Microbiologic characteristics and in vitro susceptibility to antimicrobials in a large population of patients with cardiovascular implantable electronic device infection. Jan E; Camou F; Texier-Maugein J; Whinnett Z; Caubet O; Ploux S; Pellegrin JL; Ritter P; Metayer PL; Roudaut R; Haissaguerre M; Bordachar P J Cardiovasc Electrophysiol; 2012 Apr; 23(4):375-81. PubMed ID: 22082221 [TBL] [Abstract][Full Text] [Related]
9. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin. Mohan SS; McDermott BP; Cunha BA Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736 [TBL] [Abstract][Full Text] [Related]
10. Infections associated with permanent pacemakers and implanted cardioverter-defibrillator devices. A 10-year regional study in Denmark. Smit J; Korup E; Schønheyder HC Scand J Infect Dis; 2010 Sep; 42(9):658-64. PubMed ID: 20465488 [TBL] [Abstract][Full Text] [Related]
11. Economic implications of infections of implantable cardiac devices in a single institution. Kuehn C; Graf K; Heuer W; Hilfiker A; Chaberny IF; Stiesch M; Haverich A Eur J Cardiothorac Surg; 2010 Apr; 37(4):875-9. PubMed ID: 19939696 [TBL] [Abstract][Full Text] [Related]
12. [Antibiotic treatment of device-associated endocarditis with fosfomycin and vancomycin in patients with renal insufficiency]. Bär W; Grosch H; Ahland R; Krülls-Münch J Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1818-9. PubMed ID: 16052445 [No Abstract] [Full Text] [Related]
13. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci. Napolitano LM Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494 [TBL] [Abstract][Full Text] [Related]
14. [Management of infections from cardiac implantable electronic devices: recommendations from a study panel]. Durante Mangoni E; Carbonara S; Iacobello C; Tripodi MF; Carretta A; Caprioli V; Pellegrino P; Di Biase M; Favale S; Santantonio TA; Esposito S; Nappi G; Angarano G; Utili R Infez Med; 2011 Dec; 19(4):207-23. PubMed ID: 22212160 [TBL] [Abstract][Full Text] [Related]
15. Activity of quinupristin/dalfopristin against gram-positive bacteria: clinical applications and therapeutic potential. Rubinstein E; Bompart F J Antimicrob Chemother; 1997 May; 39 Suppl A():139-43. PubMed ID: 9511078 [TBL] [Abstract][Full Text] [Related]